BrainChip
(ASX:BRN), a producer of neuromorphic artificial intelligence IP, has announced its fourth amendment to the put option agreement with LDA Group, an affiliate of LDA
Capital.
The amendment extends the agreement, offering BrainChip access to necessary capital until June 2026.
This brings the total funding available under the POA to $140 million, with an increase of $37 million from previous commitments.
Since the inception of the POA in August 2020, the company has drawn approximately $68 million in gross proceeds.
A crucial aspect of the amendment is the addition of a minimum drawdown amount of $20 million, to be drawn by June 30, 2026.
BrainChip will issue 40 million collateral shares by the earlier of the next capital call or June 30, 2025, adhering to Listing Rule 7.1 placement capacity.
"No additional fees are incurred under the amendment of the POA. The capital raised will drive the development of Akida 2.0 products and support commercialisation and expansion efforts," stated Sean Hehir, CEO of BrainChip.
Hehir elaborated, "With the growing momentum of our 2nd generation AkidaTM products, and our exceptional TENNS solutions which excel in streaming data at the edge, we recognise the need to accelerate investments to drive growth and solidify our market leadership."
"While maintaining a prudent approach to cash management, having access to funding from our well-respected partners at LDA Group, enhances our ability to ensure business continuity and remain competitive against well-capitalized industry peers," the executive added.